- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.10. | Serving up customer experience excellence | ||
| 29.10. | Merck acquires oncology spinout Modifi Biosciences in deal worth $1.3bn | ||
| 29.10. | BeiGene's Tevimbra recommended by CHMP for gastric and oesophageal cancer | ||
| 29.10. | Medicines can be beyond reach - unless… | ||
| 28.10. | J&J's Darzalex regimen approved by EC for newly diagnosed multiple myeloma | ||
| 28.10. | Novartis' Kisqali receives CHMP recommendation for early breast cancer patients | ||
| 28.10. | The role of innovation in shaping the future of health communications | ||
| 25.10. | Pfizer and Triana enter molecular glue degrader partnership worth over $1.5bn | ||
| 25.10. | AstraZeneca's Voydeya recommended by NICE to treat rare blood disorder PNH | ||
| 25.10. | ESMO 2024 - how pharma is breathing life into cancer comms | ||
| 24.10. | Eli Lilly's Alzheimer's drug Kisunla approved by MHRA but not recommended by NICE | ||
| 24.10. | Ipsen's Iqirvo recommended by NICE to treat rare liver disease primary biliary cholangitis | ||
| 24.10. | Unlocking potential: key life sciences priorities for the Autumn Budget | ||
| 24.10. | Investment and impact: navigating the complexities of a European launch | ||
| 23.10. | Merck's Keytruda recommended by NICE to reduce risk of lung cancer recurrence | ||
| 23.10. | AstraZeneca/Ionis' Wainzua receives positive CHMP opinion to treat rare disease ATTRv-PN | ||
| 23.10. | Inizio Medical appoints Patrick Giordani as senior vice president, AI solutions architect | ||
| 23.10. | The make-or-break moment for your biopharma product success | ||
| 22.10. | Astellas' Vyloy approved by FDA as first-line gastric cancer combination treatment | ||
| 22.10. | Novo Nordisk's Alhemo recommended by CHMP for haemophilia A and B | ||
| 22.10. | Optimising MSL impact in clinical trials: addressing the industry's diversity challenge | ||
| 21.10. | Roche's Alecensa receives NICE recommendation to treat ALK-positive lung cancer | ||
| 21.10. | British Medical Association GP committee votes to phase out physician associates | ||
| 21.10. | Influencing the future of healthcare communications | ||
| 18.10. | AbbVie's continuous Parkinson's disease therapy Vyalev approved by FDA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
